Lesko Gets Answers from Members of the FDA and NIH

WASHINGTON, D.C.—U.S. Congresswoman Debbie Lesko (AZ-08) joined the House Energy and Commerce Committee’s Health Subcommittee to question members of the National Institutes of Health (NIH) on what would need to be done to ensure any expanded access program is fair for its beneficiaries and why the Food and Drug Administration approved a drug when the advisory panel was not overwhelmingly in favor of approval.

 

Watch full remarks below:

Stay Connected

Use the form below to sign up for my newsletter and get the latest news and updates directly to your inbox.